Ipamorelin: Growth Hormone Peptide Benefits, Dosage, and What to Expect

Ipamorelin Benefits

• Growth hormone stimulation: Ipamorelin produces dose-dependent GH release from the pituitary, raising IGF-1 levels. Unlike exogenous HGH, this preserves the pulsatile pattern and pituitary-hypothalamic feedback loop.
• Body composition: Elevated GH and IGF-1 support lean mass preservation, fat metabolism (particularly visceral fat), and improved body composition over 3–6 month protocols.
• Recovery and sleep: GH is predominantly released during deep sleep. Ipamorelin administered at bedtime amplifies this natural pulse, improving tissue repair and sleep quality.
• Bone density: IGF-1 stimulates osteoblast activity; long-term GH optimization supports bone density preservation.
• Anti-aging: GH declines approximately 15% per decade after age 30 (somatopause). GH secretagogues address this decline without the risks of exogenous HGH.

Ipamorelin Dosage (Research Reference)

Standard ipamorelin protocols from clinical research and compounding pharmacy guidance:

• Dose range: 200–300 mcg per injection, 1–3 times daily
• Most common protocol: 200–300 mcg once daily at bedtime (to amplify the natural nocturnal GH pulse)
• Advanced protocols: 200 mcg 2–3x daily (morning before exercise, around workout, and bedtime) to maximize GH pulsatility throughout the day
• Stacked with CJC-1295: Ipamorelin 200–300 mcg + CJC-1295 (no DAC) 100–200 mcg per injection, 1–3x daily
• Cycle length: 3–6 months on, with 1–2 months off to prevent pituitary desensitization

Ipamorelin Units, Reconstitution, and Dosing by Goal

The correct ipamorelin reconstitution and insulin-syringe unit reading depends on the vial strength and the amount of bacteriostatic water added. A fixed number of units cannot apply to every vial.

Use this calculation for a standard U-100 insulin syringe:

1. Convert the vial content from milligrams to micrograms by multiplying the milligrams by 1,000.
2. Divide the total micrograms by the milliliters of bacteriostatic water added to find the concentration per milliliter.
3. Divide that concentration by 100, since a U-100 syringe contains 100 units per milliliter.

The full formula is:

mcg per unit = (vial content in mg × 1,000) ÷ mL of bacteriostatic water ÷ 100

Then divide the intended dose in micrograms by the calculated micrograms per unit to find the syringe reading. The standard 200 to 300 mcg reference dose equals 0.2 to 0.3 mg, but the milligram conversion alone does not reveal the injection volume or syringe units.

Ipamorelin dosing does not have separate published ranges for weight loss, muscle growth, or general recovery. The research discussed on this page relates dose to growth hormone pulse amplitude through the ghrelin receptor. It does not establish one ipamorelin dose for fat loss and another for muscle growth. Increasing the dose solely because the goal is muscle growth is not supported by those reference sources.

There is also no dedicated female ipamorelin protocol in the reference sources used here. Women commonly begin at the lower end of the same 200 to 300 mcg range rather than using a separate female-specific range. The vial label, prescribed concentration, and reconstitution volume must all match before converting any dose into syringe units.

Ipamorelin vs GHRP-2 and GHRP-6

Ipamorelin's selectivity is its key advantage. The significant cortisol and prolactin spikes from GHRP-2 and GHRP-6 can blunt the anabolic effect of GH and cause side effects that make those compounds less suitable for long-term anti-aging protocols.

Choosing between a GHRP and a GHRH analog? See our ipamorelin vs sermorelin comparison for how the two pathways differ and why they're often stacked.

What to Expect: Timeline

• Week 1–2: Improved sleep quality and depth (often the first reported benefit). Some users notice better post-workout recovery.
• Week 3–4: Energy levels often improve. Lab results begin showing IGF-1 movement from baseline.
• Month 2–3: Body composition changes become measurable — modest lean mass increase, some visceral fat reduction with appropriate diet.
• Month 4–6: More substantial body composition changes, skin quality improvements, and recovery benefits are typically most pronounced in this window.